Condition 1: Blood Pressure. Condition 2: Heart Rate. Elevated blood-pressure reading, without diagnosis of hypertension Tachycardia, unspecified
Conditions
Interventions
Intervention 1: Intervention group A: Patients in this group after lying on the bed and monitoring connection with 0.5 mg per kg body weight SuccinylCholine, 2 mg per kg body weight Thiopental and 1 m
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
4 Years to 16 Years
Inclusion criteria
Inclusion criteria: Children 4 to 16 years Candidate for ETC ASA Class I & II
Exclusion criteria
Exclusion criteria: Patients with a history of seizures, Heart failure, Kidney failure, Liver failure, Respiratory failure History of allergy to the studied drugs Addiction to psychotropic substances History of egg allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart Rate. Timepoint: Before drug injection and 1, 2, 3, 5 and 10 minutes after anesthesia. Method of measurement: ECG.;Blood Pressure. Timepoint: Before drug injection and 1, 2, 3, 5 and 10 minutes after anesthesia. Method of measurement: Manometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of anesthesia. Timepoint: From the beginning of anesthesia to the end of recovery. Method of measurement: Timer.;Duration of seizures. Timepoint: From the moment of the beginning of contractions until the time of relaxation. Method of measurement: Timer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDorna Masaely
Esfahan University of Medical Sciences
Outcome results
None listed